Pioneering Cure to save lives


Stay up to date on our HIV clinical trial progress by visiting our HIV project website, Addimmune.


Patients deserve a cure, not just lifelong medication. We're running out of time.  Join the fight for a cure.

American Gene Technologies® harnesses the power of gene therapy to relieve human suffering from serious diseases.

Latest News

Addimmune will build upon the success of American Gene Technologies Phase 1 HIV clinical trial, accelerating the clinical development with dedicated investment and singular focus on HIV.

American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primary and secondary endpoints of its AGT103-T Phase 1 trial.


Life Sciences Voice: Why Focus on Treating Diseases Instead of Curing Them

So much money has been poured into treating diseases, but far less into actually curing them. The pharmaceutical industry has done an incredible job of developing highly profitable treatments for a wide range of diseases and conditions.